Literature DB >> 25931036

⁶⁸Ga-PSMA imaging of metastatic breast cancer.

Mike Sathekge1, Moshe Modiselle, Mariza Vorster, Neo Mokgoro, Nozipho Nyakale, Brenda Mokaleng, Thomas Ebenhan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25931036     DOI： 10.1007/s00259-015-3066-x

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  5 in total

1.  (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.

Authors:  Emre Demirci; Meltem Ocak; Levent Kabasakal; Clemens Decristoforo; Zübeyir Talat; Metin Halaç; Bedii Kanmaz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-23       Impact factor: 9.236

2.  Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers.

Authors:  Alla Gabriella Wernicke; Sonal Varma; Eleni A Greenwood; Paul J Christos; K S Clifford Chao; He Liu; Neil H Bander; Sandra J Shin
Journal:  APMIS       Date:  2013-12-05       Impact factor: 3.205

3.  Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Authors:  Ali Afshar-Oromieh; Christian M Zechmann; Anna Malcher; Matthias Eder; Michael Eisenhut; Heinz G Linhart; Tim Holland-Letz; Boris A Hadaschik; Frederik L Giesel; Jürgen Debus; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-27       Impact factor: 9.236

4.  The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Authors:  Ali Afshar-Oromieh; Eleni Avtzi; Frederik L Giesel; Tim Holland-Letz; Heinz G Linhart; Matthias Eder; Michael Eisenhut; Silvan Boxler; Boris A Hadaschik; Clemens Kratochwil; Wilko Weichert; Klaus Kopka; Jürgen Debus; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-11-20       Impact factor: 9.236

5.  Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases.

Authors:  Natsuko Nomura; Sandra Pastorino; Pengfei Jiang; Gage Lambert; John R Crawford; Marco Gymnopoulos; David Piccioni; Tiffany Juarez; Sandeep C Pingle; Milan Makale; Santosh Kesari
Journal:  Cancer Cell Int       Date:  2014-03-20       Impact factor: 5.722
  5 in total
  20 in total

1.  Paget bone disease demonstrated on (68)Ga-PSMA ligand PET/CT.

Authors:  C Artigas; J Alexiou; C Garcia; Z Wimana; F-X Otte; T Gil; R Van Velthoven; P Flamen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-27       Impact factor: 9.236

2.  (68)Ga-PSMA PET/CT imaging in primary hepatocellular carcinoma.

Authors:  Arun Sasikumar; Ajith Joy; Raviteja Nanabala; M R A Pillai; Boben Thomas; K R Vikraman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-08       Impact factor: 9.236

3.  68Ga-Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma.

Authors:  Rita Chahinian; Ahmad El-Amine; Sayed Matar; Mostafa Annan; Ali Shamseddine; Mohamad Haidar
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

Review 4.  New frontiers in prostate cancer imaging: clinical utility of prostate-specific membrane antigen positron emission tomography.

Authors:  Asim Afaq; Deepak Batura; Jamshed Bomanji
Journal:  Int Urol Nephrol       Date:  2017-02-14       Impact factor: 2.370

5.  Prostate-specific membrane antigen (PSMA) expression in breast cancer and its metastases.

Authors:  Mariz Kasoha; Clara Unger; Erich-Franz Solomayer; Rainer M Bohle; Claudia Zaharia; Fadi Khreich; Stefan Wagenpfeil; Ingolf Juhasz-Böss
Journal:  Clin Exp Metastasis       Date:  2018-02-10       Impact factor: 5.150

Review 6.  Molecular Imaging in Breast Cancer.

Authors:  Daniela Miladinova
Journal:  Nucl Med Mol Imaging       Date:  2019-10-16

Review 7.  Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.

Authors:  Steven P Rowe; Alexander Drzezga; Bernd Neumaier; Markus Dietlein; Michael A Gorin; Michael R Zalutsky; Martin G Pomper
Journal:  J Nucl Med       Date:  2016-10       Impact factor: 10.057

8.  Detection of 18F-FDG PET/CT Occult Lesions With 18F-DCFPyL PET/CT in a Patient With Metastatic Renal Cell Carcinoma.

Authors:  Steven P Rowe; Michael A Gorin; Hans J Hammers; Martin G Pomper; Mohammad E Allaf; Mehrbod Som Javadi
Journal:  Clin Nucl Med       Date:  2016-01       Impact factor: 7.794

Review 9.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 10.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.